抗原
免疫系统
佐剂
卵清蛋白
交叉展示
CTL公司*
细胞毒性T细胞
抗原呈递
PLGA公司
癌症免疫疗法
树突状细胞
抗原提呈细胞
CpG寡核苷酸
生物
免疫疗法
免疫学
材料科学
T细胞
CD8型
生物化学
体外
DNA甲基化
基因表达
基因
作者
Sunyoung Kim,Hathaichanok Phuengkham,Young‐Woock Noh,Hong‐Guen Lee,Soong Ho Um,Yong Taik Lim
标识
DOI:10.1002/adfm.201603651
摘要
The well‐designed activation of dendritic cells (DCs) by enhancing the delivery of antigens and immunostimulatory adjuvants into DCs is a key strategy for efficient cancer immunotherapy. Antigen‐antibody immune complexes (ICs) are known to directly bind to and cross‐link Fc‐gamma receptors (FcγRs) on DCs, which induce enhanced migration of DCs to draining lymph nodes through the up‐regulation of the chemokine receptor CCR7 and cross‐presentation inducing cytotoxic T lymphocyte (CTL) response against tumor antigen. In this study, ICs mimicking synthetic vaccine nanoparticles (NPs) are designed and synthesized by the coating of poly (lactic‐ co ‐glycolic acid) (PLGA) NPs containing adjuvant (CpG oligodeoxynuleotides (ODNs) as toll‐like receptor 9 ligands) with ovalbumin (OVA) proteins (as model antigens) and by the formation of OVA–OVA antibody ICs. Through the combination of FcγRs‐mediated efficient antigen uptake and CpG ODNs‐based immunostimulation, the secretion of TNF‐α (12.3‐fold), IL‐6 (7.29‐fold), and IL‐12 (11‐fold), homing ability to lymph nodes (7.5‐fold), and cross‐presentation (83.8‐fold IL‐2 secretion) are dramatically increased in DCs treated with PLGA(IC/CpG) NPs. Furthermore, mice vaccinated with DCs treated with PLGA(IC/CpG) NPs induced significant tumor (EG7‐OVA) growth inhibition as well as prolonged survival through CTL‐mediated enhanced cytotoxicity, antigen‐specific responses, and IFN‐γ secretion.
科研通智能强力驱动
Strongly Powered by AbleSci AI